Publications (21) Publications de Eva María Sanz Merino

2015

  1. Sustained interleukin-1β exposure modulates multiple steps in glucocorticoid receptor signaling, promoting split-resistance to the transactivation of prominent anti-inflammatory genes by glucocorticoids

    Mediators of Inflammation, Vol. 2015

2010

  1. Ordering human CD34+CD10-CD19+ pre/pro-B-cell and CD19- common lymphoid progenitor stages in two pro-B-cell development pathways

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, Núm. 13, pp. 5925-5930

2009

  1. Disminución de la capacidad fagocítica de las células dendríticas mieloides del sistema inmune intestinal en ratas cirróticas con ascitis

    XXXIV Congreso Anual de la Asociación Española para el Estudio del Hígado

  2. Evolución de la activación sistémica del sistema inmune-inflamatorio en cirrosis experimental: relación con la inflamación en ganglio linfático mesentérico (GM) y hepático (GH)

    XXXIV Congreso Anual de la Asociación Española para el Estudio del Hígado

2005

  1. El tratamiento con el inmunomodulador AM3 reduce el estado proinflamatorio sistémico y la circulación hiperdinámica de ratas con cirrosis

    XXX Congreso Nacional de la Sociedad Española para el Estudio del Hígado

  2. Mecanismos del sistema inmune en la patogenia de las enfermedades: implicaciones médicas

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 9, Núm. 34, pp. 2219-2224

  3. Mesenteric Th1 polarization and monocyte TNF-α production: First steps to systemic inflammation in rats with cirrhosis

    Hepatology, Vol. 42, Núm. 2, pp. 411-419

2004

  1. Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: Amelioration with norfloxacin

    Journal of Hepatology, Vol. 40, Núm. 4, pp. 624-631

2003

  1. Human cord blood CD34+Pax-5+ B-cell progenitors: Single-cell analyses of their gene expression profiles

    Blood, Vol. 101, Núm. 9, pp. 3424-3430

2001

  1. Cell surface CD28 levels define four CD4+ T cell subsets: Abnormal expression in rheumatoid arthritis

    Clinical Immunology and Immunopathology, Vol. 99, Núm. 2, pp. 253-265

2000

  1. Obtaining biologically active IL-15 in Escherichia coli

    Biotecnologia Aplicada, Vol. 17, Núm. 4, pp. 221-224

1999

  1. Definitions and diagnostic criteria of digestive hemorrhage and its causes in cirrhosis

    Gastroenterología y hepatología, Vol. 22, Núm. 4, pp. 191-199

  2. Multivalent structure of an αβT cell receptor

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, Núm. 4, pp. 1547-1552

1998

  1. In vitro reconstitution of human B-cell ontogeny: From CD34+ multipotent progenitors to Ig-secreting cells

    Blood, Vol. 92, Núm. 12, pp. 4509-4520

1996

  1. A novel anti-Vpre-B antibody identifies immunoglobulin-surrogate receptors on the surface of human Pro-B cells

    Journal of Experimental Medicine, Vol. 183, Núm. 6, pp. 2693-2698

  2. Ordering of human bone marrow B lymphocyte precursors by single-cell polymerase chain reaction analyses of the rearrangement status of the immunoglobulin H and L chain gene loci

    Journal of Experimental Medicine, Vol. 184, Núm. 6, pp. 2217-2229

1993

  1. Glucocorticoid hormones upregulate interleukin 2 receptor α gene expression

    Cellular Immunology, Vol. 151, Núm. 2, pp. 437-450

1990

  1. OX48, a monoclonal antibody against a 70,000 MW rat activation antigen expressed by T cells bearing the high-affinity interleukin-2 receptor

    Immunology, Vol. 70, Núm. 2, pp. 210-215

1989

  1. Growth requirements of T cell hybridomas obtained by the fusion between a mouse cytolytic T cell line and the rat tumor C58NTD

    Hybridoma, Vol. 8, Núm. 1, pp. 61-71

  2. IL-2 protects T cell hybrids from the cytolytic effect of glucocorticoids. Synergistic effect of IL-2 and dexamethasone in the induction of high-affinity IL-2 receptors

    Journal of Immunology, Vol. 143, Núm. 12, pp. 4146-4151